| | | | Western blot - Kallikrein 4 antibody - Catalytic domain (ab40950)  (enlarge) | |
| |
| Product Name | Kallikrein 4 antibody - Catalytic domain |
| | See all Kallikrein 4 antibodies (4)... |
| Product type | Primary antibodies |
| Description | Rabbit polyclonal to Kallikrein 4 - Catalytic domain |
| Immunogen | Synthetic peptide based on the catalytic domain of human Kallikrein 4.(Peptide available as ab43086.) |
| Reacts with (species key) | Hu |
| Specificity | This antibody is specific for Kallikrein 4, it does not react with the other Kallikreins (1-3, 5-15). We have a range of domain specific antibodies for this target. For a full list please see all Kallikrein 4 antibodies |
| Tested applications (see key) | SDS-PAGE, WB |
|
| Abreviews | |
|
| Application notes (see key) | Recommended dilutions SDS-PAGE: Use at an assay dependent dilution. Extensive glycosylation and other posttranslational modifications give Kallikrein an apparent mass of 30-32 kDa on SDS PAGE gels. WB: 1/1000 when using colorimetric substrates such as BCIP/NBT and 1/5000 for chemiluminescent substrates. Predicted molecular weight: 27 kDa. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user. |
| Cellular localization | Secreted |
| Research areas | Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Serine protease >> Kallikreins Cancer >> Invasion/microenvironment >> ECM >> Extracellular matrix >> Kallikreins Signal Transduction >> Cytoskeleton / ECM >> Extracellular Matrix >> ECM Enzymes >> Kallikreins |
| Relevance | The human tissue Kallikrein gene family encodes 15 serine proteases. All Kallikreins share structural similarities including cysteine residues, a catalytic triad of His, Asp, and Ser residues, typically five coding exons and varied intron phases. Kallikreins are predominantly secreted as inactive zymogens prior to activation by cleavage of an N terminal peptide and all function extracellularly. Kallikreins can be activated autocatalytically, via other Kallikreins, or additional proteases. While structurally similar, Kallikrein family members have distinct functions and have key roles in many physiological and pathological processes. Many human tissue Kallikreins also show promise as cancer biomarkers, which may facilitate earlier detection and characterization of many forms of cancer.
Kallikrein 4 (hK4) was first described as enamel matrix serine proteinase 1, a serine protease involved in degradation of amelogenin during tooth development and tooth enamel turnover. Unlike another enamel processing enzyme, MMP20, hK4 is not restricted to dental tissues and has been identified in a range of normal and cancerous tissues and cell lines. Androgen response elements have been identified in hK4 genes and the hK4 levels have been shown to be modified by androgens and estrogens, similar to hK3 (PSA). hK4 has also been shown to activate pro-uPa by generating the two chain form after cleavage of the one chain form and thus may participate in an enzyme activation cascade. The Kallikrein 4 signal sequence is thought to be insufficient to allow secretion of hK4 and several reports indicate a predominately nuclear isolation. The hK4 structure differs from the Kallikrein 1-3 in having a shorter "kallikrein loop", the sequence thought to impart specificity to the classical kallikreins. Endogenous inhibitors include kallistatin, protein C inhibitor and alpha 1 proteinase inhibitor, although hK4 can be found complexed to a number of different proteinase inhibitors. |
| | |
| Database links | The links below go to external sites and will open in a new browser window |
| Raised in | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Purity | Immunogen affinity purified |
| Storage buffer | Preservative: 0.05% Sodium Azide Constituents: 50% Glycerol Material safety datasheets (MSDS) for this product: Glycerol MSDS Sodium Azide MSDS
|
| Form | Liquid |
| Concentration | 1.000 mg/ml |
| Storage instructions | Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. |
| Notes | Different splice variants of Kallikrein 4 encode for proteins of 195, 159 and 75 amino acids, with predicted masses of 20.6, 16.9 and 8 kDa respectively, although expression of the related proteins is unknown. |
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this Kallikrein 4 antibody - Catalytic domain is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
| See below for Kallikrein 4 antibody - Catalytic domain images, references, products related to ab40950 and other tools. |
| |
Kallikrein 4 antibody - Catalytic domain images: |
Western blot - Kallikrein 4 antibody - Catalytic domain (ab40950) All lanes : Kallikrein 4 antibody - Catalytic domain (ab40950) at 1/1000 dilution
Lane 1 : Kallikrein 4 at 0.05 µg Lane 2 : Kallikrein 4 at 0.01 µg Lane 3 : Kallikrein 4 at 0.001 µg
Predicted band size : 27 kDa Observed band size : 30 kDa (why is the actual band size different from the predicted?) Additional bands at : 50 kDa (possible post-translational modification).
Extensive glycosylation and other posttranslational modifications give Kallikrein an apparent mass of 30-32 kDa on SDS PAGE gels. |
| |
| |
| Search PubMed (MEDLINE) for references to Kallikrein 4 |
| |
Kallikrein 4 antibody - Catalytic domain - more information |
Customer reviews (feedback) regarding Kallikrein 4 antibody - Catalytic domain |
Customer FAQs regarding Kallikrein 4 antibody - Catalytic domain |
Protocols for Kallikrein 4 antibody - Catalytic domain |
Price and availability of products related to Kallikrein 4 antibody - Catalytic domain |
| |
Kallikrein 4 antibody - Catalytic domain - related products: |
| |
| |
Kallikrein 4 antibody - Catalytic domain - other tools: |
Contact Abcam with a Technical Enquiry about Kallikrein 4 antibody - Catalytic domain |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"